Avid Bioservices Inc (CDMO)

[pphmtoolong]

Peregrine potential value has greatly increased IMO since the discovery of Bavi's MOA which increases our immune systems ability to fight cancers. It then increased more IMO when Peregrine learned that Bavi increases the effectiveness of the new immune-oncology treatment created by the BPs.

Peregrine has pushed Bavi for years. Clearly, Bavi will show it's value in the chemo combo Phase III Sunrise trial by mid-2016. With Memorial Sloan Kettering and a few small clinical trials, Bavi will also show what it can do with BPs latest immune-oncology darlings during the course of the next months.

I like how this is going. When the good news comes, the market which has ignored Peregrine's potential will react when they can see the money BPs are willing to pay for a piece of Peregrine. How sweet that will be.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul